Research Article
Prognostic Significance of Neutrophil/Lymphocytes Ratio (NLR) in Predicting Recurrence of Cervical Dysplasia
Table 2
NLR subgroups and risk factors analysis.
| | NLR <2
() | NLR ≥2
() | |
| | Age (years) | 38.0 (±9.7) | 39.0 (±9.4) | 0.484 | | WBC (mean) | 6412.5 (±1523.8) | 7801.1 (±1916.8) | <0.001 | | Lymphocyte | 2371.1 (±569.2) | 1913.9 (±496.3) | 0.123 | | Neutrophil | 3392.6 (±994.6) | 5187.2 (±1504.7) | <0.001 | | Histology | | | | | CIN 1 | 27 (10.5%) | 12 (7.0%) | | | CIN 2 | 114 (44.5%) | 78 (45.3%) | | | CIN 3 | 96 (37.5%) | 66 (38.4%) | 0.597 | | CA “in situ” | 17 (6.6%) | 16 (9.3%) | | | G-CIN 2 | 1 (0.4%) | / | | | G-CIN 3 | 1 (0.4%) | / | | | Margins | | | | | Positive | 38 (14.9%) | 25 (15.3%) | 0.518 | | Negative | 215 (85.1%) | 138 (84.7%) | | | | | | | HPV post-treatment | | | | | Positive | 76 (30%) | 39 (24%) | 0.166 | | Negative | 180 (70%) | 133 (76%) | | | Recurrences | 39/256 (15.2%) | 47/172 (27.3%) | 0.003 | | CIN2+ recurrences | 17/256 (6.5%) | 18/172 (10.5%) | 0.05 | Recurrences
In free margins cones | 27/218 (12.4%) | 34/146 (23%) | 0.008 |
|
|
